QR-Code

Clinical significance of novel biomarkers to predict the natural course of hepatitis B infection

Background and aimChronic hepatitis B (CHB) can be divided into immune tolerance (IT), immune clearance (IC), hepatitis B e antigen (HBeAg)-negative inactive/quiescent carrier (ENQ), and HBeAg-negative hepatitis (ENH) phases. The conventional biomarkers used to distinguish these phases have limitati...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Weikang Wu, Xiaojie Yuan, Weilu Zhang, Haowei Zhou, Xiangyu Kong, Zhen He, Ting Fu, Wenhua Zhang, Wenling Jia, Chunhui Liang, Haitao Tang, Fengmei Wang, Yancheng Ye, Zhongjun Shao, Zhaohua Ji
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2022-10-01
Schriftenreihe:Frontiers in Public Health
Schlagworte:
hepatitis B
novel biomarkers
phase
HBV RNA
HBcrAg
HBV DNA
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1037508/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge